BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 38598668)

  • 1. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.
    Nayak L; Bettegowda C; Scherer F; Galldiks N; Ahluwalia M; Baraniskin A; von Baumgarten L; Bromberg JEC; Ferreri AJM; Grommes C; Hoang-Xuan K; Kühn J; Rubenstein JL; Rudà R; Weller M; Chang SM; van den Bent MJ; Wen PY; Soffietti R
    Neuro Oncol; 2024 Jun; 26(6):993-1011. PubMed ID: 38598668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.
    Soffietti R; Bettegowda C; Mellinghoff IK; Warren KE; Ahluwalia MS; De Groot JF; Galanis E; Gilbert MR; Jaeckle KA; Le Rhun E; Rudà R; Seoane J; Thon N; Umemura Y; Weller M; van den Bent MJ; Vogelbaum MA; Chang SM; Wen PY
    Neuro Oncol; 2022 Jun; 24(6):855-871. PubMed ID: 34999836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities.
    Hiemcke-Jiwa LS; Leguit RJ; Snijders TJ; Jiwa NM; Kuiper JJW; de Weger RA; Minnema MC; Huibers MMH
    Crit Rev Oncol Hematol; 2018 Jul; 127():56-65. PubMed ID: 29891112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications.
    Boire A; Brandsma D; Brastianos PK; Le Rhun E; Ahluwalia M; Junck L; Glantz M; Groves MD; Lee EQ; Lin N; Raizer J; Rudà R; Weller M; Van den Bent MJ; Vogelbaum MA; Chang S; Wen PY; Soffietti R
    Neuro Oncol; 2019 May; 21(5):571-584. PubMed ID: 30668804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Utility of Liquid Biopsy in Central Nervous System Malignancies.
    Nevel KS; Wilcox JA; Robell LJ; Umemura Y
    Curr Oncol Rep; 2018 Jun; 20(8):60. PubMed ID: 29876874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma.
    Yamagishi Y; Sasaki N; Nakano Y; Matushita Y; Omura T; Shimizu S; Saito K; Kobayashi K; Narita Y; Kondo A; Shiokawa Y; Nagane M; Ichimura K
    Cancer Sci; 2021 Nov; 112(11):4702-4710. PubMed ID: 34523186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
    Downs BM; Ding W; Cope LM; Umbricht CB; Li W; He H; Ke X; Holdhoff M; Bettegowda C; Tao W; Sukumar S
    Clin Epigenetics; 2021 May; 13(1):104. PubMed ID: 33952317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy.
    Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.
    Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
    Ferreri AJM; Calimeri T; Lopedote P; Francaviglia I; Daverio R; Iacona C; Belloni C; Steffanoni S; Gulino A; Anghileri E; Diffidenti A; Finardi A; Gagliardi F; Anzalone N; Nonis A; Furlan R; De Lorenzo D; Terreni MR; Martinelli V; Sassone M; Foppoli M; Angelillo P; Guggiari E; Falini A; Mortini P; Filippi M; Tarantino V; Eoli M; Ciceri F; Doglioni C; Tripodo C; Locatelli M; Cangi MG; Ponzoni M
    Br J Haematol; 2021 May; 193(3):497-505. PubMed ID: 33620087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature.
    Natsumeda M; Shibuma S; Takahashi H; On J; Mouri Y; Tomikawa K; Fujiwara H; Watanabe J; Tsukamoto Y; Okada M; Takeda R; Shimizu H; Takizawa J; Kakita A; Oishi M
    Brain Tumor Pathol; 2024 Apr; 41(2):85-91. PubMed ID: 38597999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
    Mattox AK; Yan H; Bettegowda C
    Neuro Oncol; 2019 Dec; 21(12):1509-1518. PubMed ID: 31595305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
    Baraniskin A; Chomiak M; Ahle G; Gress T; Buchholz M; Turewicz M; Eisenacher M; Margold M; Schlegel U; Schmiegel W; Hahn S; Schroers R
    J Neurooncol; 2018 May; 137(3):463-468. PubMed ID: 29327175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas.
    Valerius AR; Webb MJ; Hammad N; Sener U; Malani R
    Curr Oncol Rep; 2024 Apr; 26(4):377-390. PubMed ID: 38488990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases.
    Iriyama C; Murate K; Iba S; Okamoto A; Goto N; Yamamoto H; Kato T; Mihara K; Miyama T; Hattori K; Kajiya R; Okamoto M; Mizutani Y; Yamada S; Tsukamoto T; Hirose Y; Mutoh T; Watanabe H; Tomita A
    Cancer Med; 2023 Aug; 12(16):16972-16984. PubMed ID: 37501501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
    Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
    Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS.
    Baraniskin A; Schroers R
    CNS Oncol; 2014 Jan; 3(1):77-85. PubMed ID: 25054902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the
    Zorofchian S; Lu G; Zhu JJ; Duose DY; Windham J; Esquenazi Y; Ballester LY
    Front Oncol; 2018; 8():382. PubMed ID: 30294590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma.
    Hiemcke-Jiwa LS; Leguit RJ; Snijders TJ; Bromberg JEC; Nierkens S; Jiwa NM; Minnema MC; Huibers MMH
    Br J Haematol; 2019 Jun; 185(5):974-977. PubMed ID: 30408153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.